Invested Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Invested Advisors's BMY Position: Q2 2026 in Review
Invested Advisors reduced its Bristol-Myers Squibb (BMY) stake by 2% in Q2 2026, selling an estimated $8.5K and leaving 7,241 shares worth $417K. The position accounts for 0.37% of the portfolio, ranked #73.
Invested Advisors first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $448K in Q1 2026. 2,527 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Invested Advisors held 7,241 shares of Bristol-Myers Squibb worth $417K as of Q2 2026.
- Invested Advisors sold 148 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.5K.
- Bristol-Myers Squibb made up 0.37% of Invested Advisors's portfolio in Q2 2026, its #73 holding.
- Invested Advisors first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
- Invested Advisors's Bristol-Myers Squibb position peaked at $448K in Q1 2026.
- 2,527 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Invested Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.